Albemarle (NYSE:ALB – Free Report) had its target price reduced by BMO Capital Markets from $150.00 to $140.00 in a research ...

S&P Global (NYSE:SPGI – Get Free Report) had its price objective upped by analysts at BMO Capital Markets from $576.00 to $590.00 in a research report issued to clients and investors on ...

BMO Capital Markets adjusted their outlook on DuPont (NYSE:DD), increasing the price target from the previous $105.00 to a ...

BMO Capital Markets maintained its Market Perform rating on Keyera Corp . (TSX:KEY:CN) (OTC: KEYUF), with a steady price target of Cdn$45.50. The stock experienced a notable increase at the opening of ...

BMO Capital analyst Evan Seigerman lowered the firm’s price target on Biogen (BIIB) to $139 from $156 and keeps a Market Perform rating on the ...

BMO Capital raised the firm’s price target on DuPont (DD) to $112 from $105 and keeps an Outperform rating on the shares after its Q4 earnings ...

BMO Capital lowered the firm’s price target on Harley-Davidson (HOG) to $35 from $40 and keeps an Outperform rating on the ...

Wednesday afternoon's sale of $42 billion in 10-year notes tailed by 1 basis point and was met with non-dealer bidding that was slightly below average, according to BMO Capital Markets strategist Vail ...

Focus on 42 stocks with solid dividend growth as inflation runs rampant Belski and his colleagues at BMO Capital Markets have nine investing strategy portfolios that can serve as models for investors.

Jan 13 (Reuters) - BMO Capital Markets (BMO.TO), opens new tab agreed to pay more than $40 million to settle U.S. Securities and Exchange Commission charges it failed to properly supervise ...

Signs of resurgent inflation shown in January's consumer-price index can't be "easily explained away" by seasonal factors, and pressure will build on the Federal Reserve to stay on hold for a ...